Intra-Arterial Chemotherapy for Head and Neck Cancer: Experiences from Three Continents

Surgical Oncology Clinics of North America

Volumn 17, Issue 4, 2008, Pages 919-933

  Robbins, K Thomas ^a   Homma, Akihiro ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; SODIUM THIOSULFATE;

ARTERY CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CRANIAL NEUROPATHY; DRUG MEGADOSE; EUROPE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CANCER; HUMAN; JAPAN; KAPLAN MEIER METHOD; MOUTH CARCINOMA; NEPHROTOXICITY; NEUROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARANASAL SINUS CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 49649122416     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.04.015     Document Type: Review

References (44)

1. Dedrick R.L. Arterial drug infusion: pharmacokinetic problems and pitfalls. J Natl Cancer Inst 80 (1988) 84-89
2. Howell S.B. Pharmacokinetic principles of regional chemotherapy. Contr Oncol 29 (1988) 1-8
3. Howell S.B., Pfeifle C.E., Wung W.E., et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Annals of Internal Medicine 97 (1982) 845-851
4. Howell S.B., and Taetle R. The effect of sodium thiosulfate on cis dichlorodaimminedplatin (II) nephrotoxicity and antitumor activity in the L1210 leukemia. Cancer Treat Rep 64 (1980) 611-615
5. Elferink F., van der Vijgh W.J., Klein I., et al. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 32 (1986) 642-645
6. Kirmani S., Lucas W.E., Kim S., et al. A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment of ovarian carcinoma. J Clin Oncol 9 4 (1991) 649-657
7. Goel R., Cleary S.M., Horton C., et al. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst 81 (1989) 1552-1560
8. Shea M., Koziol J.A., and Howell S.B. Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35 (1984) 419-425
9. Howell S.B. Editorial: improving the therapeutic index of intra-arterial cisplatin chemotherapy. Eur J Cancer Clin Oncol 25 (1989) 775-776
10. Wolpert S.M., Kwan E.S., Heros D., et al. Selective delivery of chemotherapeutic agents with a new catheter system. Radiology 166 (1988) 547-549
11. Forastiere A.A., Baker S.R., Wheeler R., et al. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol 5 (1987) 1601-1606
12. Cheung D.K., Regan J., Savin M., et al. A pilot study of intra-arterial chemotherapy with cisplatin in locally advanced head and neck cancers. Cancer 61 (1988) 903-908
13. Lee Y.Y., Dimery I.W., Van Tassel P., et al. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol Head Neck Surg 115 (1989) 503-511
14. Robbins K.T., Storniolo A.M., Kerber C., et al. Rapid superselective high dose cisplatin infusion for advanced head and neck malignancies. Head Neck 14 (1992) 364-371
15. Richard J.M., Sancho H., Lepintre Y., et al. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 34 (1974) 491-496
16. Molinari R., Jortay A., Sancho-Garnier H., et al. A randomized EORTC trial comparing intra-arterial infusion with methotrexate vs bleomycin as initial therapy in carcinoma. Eur J Cancer Clin Oncol 18 (1982) 807-812
17. Richard J.M., Kramar A., Molinari R., et al. Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 27 (1991) 821-827
18. Robbins K.T., Vicario D., Seagren S., et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168 (1994) 419-422
19. Robbins K.T., Kumar P., Regine W.F., et al. Efficacy of supradose intra-arterial targeted (SIT) cisplatin (P) and concurrent radiation therapy (RT) in the treatment of unresectable stage III-IV head and neck carcinoma: the memphis experience. Int J Radiat Oncol Biol Phys 38 (1997) 263-271
20. Rasch C, Balm A, Kroger R, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer, early results of a phase III trial. American Head And Neck Society Annual Meeting and Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer Meeting Program Chicago, Illinois, 2006. p. 84.
21. Lee Y.Y., Wallace S., Dimery I., et al. Intra-arterial chemotherapy of head and neck tumors. AJNR Am J Neuroradiol 7 (1986) 343-348
22. Papadimitrakopoulou V.A., Ginsberg L.E., Garden A.S., et al. Intra-arterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 98 10 (2003) 2214-2223
23. Robbins K.T., Storniolo A.M., Kerber C., et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12 10 (1994) 2113-2120
24. Robbins K.T., Kumar P., Wong F.S., et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 22 7 (2000) 687-693
25. Robbins K.T., Kumar P., Harris J., et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 23 7 (2005) 1447-1454
26. Wilson W.R., Siegel R.S., Harisiadis L.A., et al. High dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127 7 (2001) 809-812
27. Spring P.M., Valentino J., Arnold S.M., et al. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Cancer 104 8 (2005) 1765-1771
28. Foote R.L., Kasperbauer J.L., Okuno S.H., et al. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive. Cancer 103 3 (2005) 559-568
29. Rabbani A., Hinerman R.W., Schmalfuss I.M., et al. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol 30 3 (2007) 283-286
30. Sullivan R.D., Miller E., and Sikes M.P. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer. Cancer 12 (1959) 1248-1262
31. Goepfert H., Jesse R.H., and Lindberg R.D. Arterial infusion and radiation therapy in the treatment of advanced cancer of the nasal cavity and paranasal sinuses. Am J Surg 126 (1973) 464-468
32. Sato Y., Morita M., Takahashi H.O., et al. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinusitis. Cancer 25 (1970) 571-579
33. Inuyama Y., Fujii M., Tanaka J., et al. Neoadjuvant chemotherapy in maxillary sinus carcinoma with cisplatinum and peplomycin intraarterial infusion. Auris Nasus Larynx 12 Suppl 2 (1985) 249-254
34. Nibu K., Sugasawa M., Asai M., et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 94 (2002) 1476-1482
35. Nishino H., Miyata M., Morita M., et al. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 89 (2000) 1925-1932
36. Mitani H., Kamata S., Nigauri T., et al. Results of treatment of patients with maxillary sinus carcinoma. Jibiinkoka Tenbo (Oto Rhino Laryngology Tokyo) 44 (2001) 180-189
37. Hattori T., Hirano T., Toyoda S., et al. Superselective continuous intra-arterial infusion therapy via superficial temporal artery for head and neck tumors. Nippon Igaku Hoshasen Gakkai Zasshi 45 (1985) 1056-1058
38. Tohnai I., Fuwa N., Hayashi Y., et al. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34 (1998) 387-390
39. Fuwa N., Ito Y., Matsumoto A., et al. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study. Cancer 89 (2000) 2099-2105
40. Imai S., Kajihara Y., Munemori O., et al. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol 21 (1995) 94-99
41. Korogi Y., Hirai T., Nishimura R., et al. Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience. Am J Roentgenol 165 (1995) 1269-1272
42. Hirai T., Korogi Y., Hamatake S., et al. Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment. Cardiovasc Intervent Radiol 22 (1999) 201-205
43. Yokoyama J., Shiga K., Saijo S., et al. Superselective intra-arterial infusion chemotherapy of high-dose cisplatin for advanced paranasal sinus carcinomas. Gan To Kagaku Ryoho 26 (1999) 967-973
44. Homma A., Furuta Y., Suzuki F., et al. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer. Head Neck 27 (2005) 65-71